Clofazimine for the treatment of tuberculosis is a research paper published in Frontiers in Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 81 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 214321/Z/18/Z
FIC NIH HHS
Grant: K43 TW011421
NIAID NIH HHS
Grant: U01 AI170426
Wellcome Trust
Grant: 203135
Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
Wellcome Trust
Grant: 214321
Evaluation of novel therapeutic strategies to accelerate bacterial clearance and host recovery in disseminated HIV-associated tuberculosis
National Institutes of Health
Grant: 1K43TW011421-01
Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis
National Institutes of Health
Grant: 3U01AI170426-04S2
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
Wellcome Trust
Fields of Study
Keywords